Fortfahren mit
A3832
Adrenomedullin Fragment 22-52 human
≥97% (HPLC)
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 10 μg | Warenkorb auf Verfügbarkeit prüfen | CHF 62.70 | |
| 50 μg | Warenkorb auf Verfügbarkeit prüfen | CHF 208.00 CHF 156.00 |
Über diesen Artikel
Empirische Formel (Hill-System):
C159H252N46O48
CAS-Nummer:
Molekulargewicht:
3575.98
UNSPSC Code:
12352209
NACRES:
NA.26
MDL number:
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenBiochem/physiol Actions
Adrenomedullin Fragment 22-52 [ADM22-52] is used as an adrenomedullin (ADM) receptor antagonist to study the functions and mechanism of action of ADM signaling. ADM(22-52) is used to differentiate adrenomedullin binding sites in various cells and tissues.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| form powder | form powder | form powder | form powder |
| assay ≥97% (HPLC) | assay ≥90% (HPLC) | assay ≥97% (HPLC) | assay ≥97% (HPLC) |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| color white | color - | color - | color - |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
| UniProt accession no. | UniProt accession no. | UniProt accession no. | UniProt accession no. |
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Takahisa Ishikawa et al.
Oncogene, 22(8), 1238-1242 (2003-02-28)
Since it is reported that adrenomedullin (AM) upregulated by hypoxia inhibits hypoxic cell death, we examined the effects of AM antagonist (AM C-terminal fragment; AM(22-52)) on the growth of pancreatic cancer cells. We, for the first time, demonstrated that AM
Agnieszka Ziolkowska et al.
International journal of molecular medicine, 11(5), 613-615 (2003-04-10)
Adrenomedullin (ADM) and its receptors are expressed in the adrenal cortex, where ADM is currently known to inhibit agonist-stimulated aldosterone secretion from zona glomerulosa (ZG), without affecting either basal aldosterone release or the secretory activity of zona fasciculata-reticularis (ZF/R) cells.
Jing Hui Yang et al.
Regulatory peptides, 158(1-3), 19-25 (2009-06-16)
Intermedin (IMD) is a novel peptide related to calcitonin gene-related peptide (CGRP) and adrenomedullin (ADM). Proteolytic processing of a larger precursor of IMD yields a biologically active C-terminal fragment IMD(1-53). We aimed to observe the cardioprotective antifibrotic effects of IMD(1-53)
Global Trade Item Number
| SKU | GTIN |
|---|---|
| A3832-50UG | 04061833368046 |
| A3832-10UG | 04061832818948 |